A phase II randomized trial of RAdium-223 dichloride and SABR Versus SABR for oligomEtastatic prostate caNcerS (RAVENS)

Overview of attention for article published in BMC Cancer, June 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 1 news outlet

twitter: 5 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 56 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Phuoc T. Tran, MD, PhD: Focus on Translational Medicine

Doc Wire News, 14 Feb 2022

Phuoc T. Tran, MD, PhD— Professor and Vice Chair for Research in the Department of Radiation Oncology, University of Maryland…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.